Why Breast Cancer Is Increasing In Younger Women, Explained

Creator: Dr. Abu Bakar
Published: 2026-03-11T08:13:50+00:00
Keywords: Breast Cancer

The growing numbers of young women with breast cancer, means that prevention and screening programs, as well as

Written and medically reviewed byDr. Abu BakarContributing writer · PharmD, PhD (Pharmacology)

March 11, 2026 · 16 min read

Woman holds pink ribbon for breast cancer awareness

The growing numbers of young women with breast cancer, means that prevention and screening programs, as well as long-term follow-up, are conceptualized differently by clinicians, health care systems, and their patients. The biology of the tumors and women’s decisions about their reproductive years also impact the management and long-term outcomes of young women with breast cancer, who, on average, will live longer than older women with breast cancer. While it does not mean that all young women have a high risk for breast cancer, a thoughtful evaluation of symptoms and individualized risk factors needs to occur at a younger age. Our health care systems are currently designed for screening older women based on age, and are not equipped to handle the needs of these younger women.

Why It Matters

While young women with breast cancer remain the majority of the cancer population treated for this disease, there is slowly a shift in the cancer care landscape towards earlier age at diagnosis. Women in their 20s, 30s, and 40s are more likely to have school-age children or young children at home, be in their prime working years, or be in school when they receive a cancer diagnosis. While cancer treatment follows a time-line, it can conflict with work and family responsibilities, and have a profound impact on patients and families’ financial stability. This financial toxicity, in turn, can affect adherence to and follow-up of cancer care and even mental health outcomes.

Most women diagnosed with breast cancer are cured of the disease and go on to live long, healthy lives. For the young woman with breast cancer, however, there is an added dimension to her treatment planning and recovery from cancer: the potential long-term effects of treatment. Some of the therapies used to treat breast cancer are known to affect a woman’s ovarian function, increase her risk for osteoporosis, heart disease, affect her memory and cognitive function and even cause sexual dysfunction. As a result, many of these effects are more pronounced in women diagnosed in their 30s and 40s, and survivorship planning is often an important consideration in their overall treatment planning.

From a medical standpoint, there is evidence to suggest that some breast cancers in young women could be more aggressive than those in older women. In addition, the biological behavior of the cancer may be different from that for which treatment protocols have been established for the older patient. As a result, the need for rapid initiation and likely a different approach to treatment is as great, if not greater. The breast cancer in young women tends to be more aggressive and may be diagnosed at a later stage because there is no routine screening for this age group. Younger women’s breast tissue is denser, which is why in some cases ultrasound or MRI may be used as the first imaging test. A new breast symptom in a young woman should not be ignored or dismissed.

To meet the needs of patients with cancer, systems of care must evolve to become more comprehensive and integrated involving a range of disciplines including, reproductive counseling/oncofertility, medical genetics, mental health, and follow-up for late effects after treatment among other disciplines. While patients and families of all ages require treatment, and follow-up for late effects, after surgery, chemotherapy and radiation, young patients with cancer and their families require special services. Patients and families may benefit from consultation and possible medical treatment from a reproductive endocrinologist for counseling and medical prevention/delay of pregnancy during cancer treatment as well as reproductive planning after cancer treatment. Young patients and their families may also benefit from in-depth counseling for anxiety/anxiety disorders, depression, body image, and relationship issues during and after cancer treatment as well as following mastectomy or during long-term hormonal therapy for cancer.

Future breast cancer in young women will demand a shift in focus to issues of screening recommendations, insurance and equity. Most mammography screening programs are designed with a maternal age bias, and focus on middle aged women. Many screening strategies are based on the notion that risk of breast cancer increases with age. However, as more young women are diagnosed with breast cancer, the health care system will be forced to adopt a risk-based approach to screening and cancer early detection, aiming for improved diagnostic accuracy with fewer unnecessary tests, false positive results and biopsies, rather than simply more screening.

Why this increase in incidence is occurring is unclear and likely multifactorial. Many factors are under consideration including reproductive changes, lifestyle and metabolic changes, environmental changes and improved detection. Many of these factors are likely to interact and affect exposure to hormones, inflammation and metabolic substances that may promote cancer many years into the future, beginning in adolescence and young adulthood.

Reproductive Patterns and Hormonal Exposure

Several reproductive exposures, including age at menarche, age at first full-term pregnancy, number of full-term pregnancies and duration of breast feeding, are thought to increase the risk of breast cancer by influencing the timing of exposure to hormones such as estrogen and progesterone and by creating a developmental environment of the breast that increases cancer risk. Many of these reproductive exposures have changed in recent decades in many countries, and have resulted in an increase in the cumulative exposure to hormones such as estrogen. Some subtypes of breast cancer are prevented by breastfeeding; to what extent a decrease in rates of breastfeeding or an increase in duration of breastfeeding will diminish this protection is not known. All of these factors have resulted in changes in population-wide trends and represent exposures that are changes in trends rather than “choices that cause cancer.” However, the shifts in trends for these exposures are likely to increase variability in risk within the population.

Lifestyle, Metabolic Health, and Inflammation

There has been increasing interest in the contribution of excess body weight, central fat and sedentary lifestyle in young women. Adipose tissue is not inert and is known to affect oestrogen levels, influence insulin and other metabolic pathway signals and increase levels of non-specific proteins that promote tumour growth. Furthermore, the two common metabolic conditions associated with increased adiposity; insulin resistance and fatty liver disease affect hormonal pathways important in breast cancer development. Alcohol intake is a modifiable exposure associated with an increased risk of breast cancer, even at moderate drinking levels. Patterns of drinking among young women have also been of recent interest.

Other factors that may affect risk by indirectly affecting risk through factors related to sleep and stress that affect risk through metabolic and endocrine pathways, leisure time physical activity, and sedentary behavior and body weight. Sleep affects risk through control of appetite, insulin action and levels of inflammation. Stress does not cause breast cancer but can have a long-term indirect effect on risk or diagnosis by influencing physical health-related behaviors and intake of alcohol, sleep, and health care seeking.

Environmental and Occupational Exposures

In addition to studying the potential effects of dietary and reproductive factors on breast cancer risk, many researchers are investigating possible effects of exposure to environmental substances. These can include endocrine-disrupting compounds that are thought to be able to affect hormone levels. Much is yet to be learned about the levels of these exposures that occur naturally in the environment as well as in daily life through work, home, personal and consumer products. Since the development of the breast tissue takes many years, exposures that occur at different ages may have a particular impact on a woman’s risk for developing breast cancer. Since much is unknown about the potential role of environmental exposures in breast cancer risk, any information that we can gather may have little relevance for individual reduction of exposure but great relevance for understanding potential impact for public health and for informing policies related to product safety and use, occupational health and safety, and environmental regulations that could reduce exposures on a population-wide basis.

Improved Detection and Awareness

Whether or not there really is an increase in the incidence of disease, in part at least, more cases are being detected and reported than would have been diagnosed in previous years. Women with breast cancer and their health care providers are more aware of the symptoms of the disease than in the past. Diagnostic imaging for a variety of symptoms is more common. The use of genetic testing for the high-risk breast cancer genes has increased dramatically in the past few years, leading to the diagnosis and management of more individuals who require both earlier and more frequent surveillance than the typical woman with breast cancer. In addition, the use of ultrasound and MRI in select patient populations has led to the detection of additional breast cancer cases that might not have been detected by mammography and clinical examination alone.

Who It Affects

Unlike the unique concerns of women over 50 with breast cancer, the unique concerns of patients with breast cancer who are under 50 relate to both their illness and their life-stage. As patients fight for their lives, patients under forty also have to contend with the demands of daily life and work-related pressures. Stress filled by the needs to be there and provide for their families. Their treatment and symptoms can also leave patients feeling fatigued and overwhelmed by questions and fears about the cancer and treatment’s affects on their life and daily habits. Patients in their forties are typically in the prime of their career and have a lot to contribute. They fear that cancer will end their lives as they know it and exacerbitate their emotional pain, fatigue, anger, and feelings of isolation. They may also grieve the loss of things they were doing before their diagnosis, such as spending quality time with their children and partners. Young women with breast cancer may have been planning to have more children, complete their family, or fulfill other personal goals and the unexpected diagnosis of cancer can be a real challenge to come to terms with.

Younger women with cancer will need to consider fertility issues and reproductive planning early on in their management. Many cancer treatments, particularly chemotherapy and radiotherapy have a damaging effect on the ovaries either temporarily or permanently reducing ovarian reserve. Patients and their families and carers may wish to discuss options for egg or embryo freezing, other methods to suppress the ovaries, how to use contraception during treatment and whether or not it is safe to become pregnant in the future. Specialist advice and management of these issues can be provided by specialist reproductive health and fertility units and it is advisable for patients and their families and carers to be rapidly referred to these units in order to make timely decisions.

Youthful survivors of cancer will need longer and more in depth survivorship support as late effects accumulate over time. Both early menopause and decreased bone density are issues that survivors and their health care providers will grapple with for years to come. Hormone-receptor positive breast cancers are typically treated long term with endocrine (hormone) therapy. The impact of treatment on quality of life and in turn treatment adherence is often underestimated. In addition to follow-up for recurrence, second cancers and late effects, following the survivors’ overall psychosocial health and well-being is an important role of long-term follow-up care.

Unlike most medical diseases, every branch of medicine will be called upon to provide medical attention to a patient with breast cancer at some juncture from initial evaluation to survivorship. Primary care physicians and gynecologists will be the first to diagnose a breast mass in many cases, followed by evaluation and imaging by specialists in women’s imaging. A lower threshold for evaluation and imaging of women of almost any age for any persistent symptoms not characteristic of routine screening mammography needs to be adopted by the breast radiologists. Radiation oncologists will require a solid grasp of genetics in the diagnostic and treatment workup and management of the young woman with breast cancer. The medical oncologist must also be well versed in issues of fertility preservation and survivorship in these young women.

The young age at diagnosis and the long duration of cancer treatment over a patient’s lifetime will challenge health systems and payers to deliver a range of services over a long period of time to ensure optimal long-term outcomes for young patients with cancer. Health systems and payers will need to consider covering a range of services including: •Genetic counseling and testing for patients with cancer or at increased risk of developing cancer •Surveillance of patients at increased risk of developing cancer •Advanced imaging studies such as MRI for surveillance of patients at increased risk •Services and counseling related to fertility preservation for patients with cancer •Mental health, physical therapy and other services to promote health and well-being of survivors of childhood cancer •Social work services to promote quality of life and address issues of importance to families. Payers will need to make determinations about the medical necessity of coverage for a variety of additional services including: •Oocyte and embryo cryopreservation for patients with cancer •Preimplantation genetic diagnosis in families with cancer •MRI vs. other imaging studies for surveillance of patients at increased risk of developing cancer •Services and surveillance delivered in long-term survivorship clinics •Remote monitoring of patients who are on therapy for cancer. Gaps in coverage for these and other services will impact patients’ decisions, adherence to cancer surveillance and cancer prevention strategies and ultimately patient outcomes.

People and populations in their prime working years (25-64 years) need access to prevention and early detection strategies appropriate for their age group. Policies that support access to primary care, protect time off from work for medical visits, and reduce costs of evidence-based cancer screening and diagnostic services can affect stage at diagnosis and survival. In addition, public health strategies that address modifiable risk factors for cancer (such as alcohol use, obesity prevention, physical activity, and breastfeeding support) to reduce cancer risk in young adults must be practical and culturally relevant.

What Changes

Screening and Detection Approaches Need Recalibration

For the young woman, the threshold for evaluation of her breast-related symptoms should be lowered. In the absence of routine screening, the diagnosis is based upon symptom evaluation. Any new breast mass, persistent localized breast pain, nipple inversion, spontaneous or bloody nipple discharge, or skin changes such as dimpling should not be ignored and evaluated in a timely fashion. The first imaging study is often more than mammography. It may also include ultrasound, and in certain cases, MRI.

Screening for women with lobular carcinoma in situ (LCIS) will be targeted on the basis of age alone will no longer be appropriate. Future screening decisions will be informed by individual risk factors for the development of LCIS, including family history, known genetic predisposition, previous chest irradiation, other benign breast disease and the dose effect of very dense breast tissue. These decisions need to be incorporated into women’s risk assessment as part of primary care and gynaecology workflows and consistent throughout the referral pathway to high-risk breast clinics. The use of risk assessment workflows will be required.

Care Pathways Must Include Fertility and Long-Term Planning

Patients and families who are candidates for fertility preservation and reproductive counseling should be introduced to these services as early as possible and educated on the topic during treatment planning. Timely discussion and education of patients and families regarding egg or embryo banking, ovarian suppression and potential timing of pregnancy after cancer treatment, as well as types and duration of post-treatment medical contraception, sexual health and rehabilitation services, to help patients and families address issues related to hormone changes and body image and how these factors affect their relationships.

Survivorship planning should occur throughout the cancer care continuum, from diagnosis through treatment and follow-up. Children, young people and their families will benefit from survivorship plans that address cardiovascular late effects, bone late effects, mental health late effects with appropriate screening and referral, sexual health late effects, and strategies to manage and live with symptoms. Effective follow-up and care is often provided through the multidisciplinary oncology team and the child or young person’s primary care physician. For some patients and their families, care of the effects of cancer in a structured survivorship clinic can help to fill the gaps in current care and optimize quality of life.

Health systems should focus on building strong multidisciplinary teams and referral systems to manage complex cases.

For many of our younger patients treatment decisions are not limited to the traditional oncologic disciplines of medical, surgical and radiation oncology. They require a multidisciplinary approach involving other disciplines that we call our young oncology team. These team members include the reproductive endocrinologist, geneticist, psycho-oncologist/social worker and physical medicine acupuncturist/masseuse, in addition to the child’s and/or parents’ primary care physician. Importantly, timely referral to services that provide fertility preservation options and genetic counseling is also fundamental to the multidisciplinary care of young patients with cancer and their families, to permit timely counseling of patients and families regarding issues of family cancer risk and appropriate treatment considerations.

In addition to measuring delays in cancer care, there is a growing recognition that cancer care systems should also provide patient navigation. This would include support to patients and families to contact the team for scheduled appointments as needed, contact the insurance company for pre-authorization when necessary, arrange transportation to and from the center for appointments, and complete any necessary paperwork to return to work for patients who are off work for treatment, follow-up, and recovery. Many of the structural delays in care as well as the delays due to lack of paid time off from work for cancer-related issues and lengthy travel to the academic cancer center from patients’ homes for consultation and treatment could be avoided with effective patient navigation.

Policy and Payer Actions Are Required

Coverage of evidence-based fertility preservation, genetic counseling and cancer surveillance for young women at risk for cancer will play a significant role in determining outcomes. Variability in coverage will coerce young women to make difficult decisions within a short timeframe while shouldering the financial responsibility for those choices. Reducing patient cost as well as streamlining the prior authorization process is essential to enable timely opportunities for fertility preservation as well as cancer surveillance.

Support for the health of younger adults with cancer and their survivor’s requires the development and implementation of protections and policies in both public health and the workplace. In order to support adherence to treatment and good survivorship, patients and survivors need access to paid medical leave, job protection, and other policies and protections. Community-based programs for healthy eating and physical activity for cancer prevention, programs and policies that support breastfeeding, and strategies for reducing alcohol-related harm can be highly effective when messages are framed within a cultural context.

What Clinicians Can Do Now

Persistent symptoms of breast disease in young women should be taken seriously. Document the duration and character of the patient’s symptoms and perform a thorough clinical examination. Every delay in diagnostic imaging and evaluation should be particularly avoided. The patient and her family should be counselled as to their risk for breast cancer, including their reproductive and medical histories. The patient should be referred for genetics evaluation if criteria for potentially inherited risk are met.

Shared decision-making is particularly important for young women with breast cancer, for whom treatment choices have different trade-offs than for older women. Treatment choices for young women with breast cancer will impact their life plans and affect both long- and short-term health. High-quality shared decision-making requires a thorough discussion of these trade-offs, as well as some brief but supportive interaction that makes the patient feel heard without drowning her in information. Such communication can even help patients comply with longer treatment programs.

Looking Ahead

Moving forward will involve progressing from predicting risks imprecisely to making predictions more accurately, from having inadequate methods of early detection in high risk populations to better methods for the task, and from having inadequate long-term survivorship systems that span decades to better systems. Improved risk models that include genetics, mammography parameters such as percent density, and other factors including reproductive and metabolic will allow us to identify the group of women who will benefit from an earlier initiation of screening. Prevention strategies for young women that promote healthy metabolic patterns in adolescents and young women may become increasingly important as we incorporate a life-course approach to breast cancer risk.

Let’s use this moment in our demographic history to make sure that prevention, detection, treatment and survivorship programs for breast cancer serve ALL women with breast cancer. Clinicians need to provide quality care for their patients’ reported symptoms and connect the dots for their patients and their families about the relation between risk factors and screening practices. Policies also need to be developed to remove financial barriers to effective care for all women, especially the young women who are increasingly diagnosed with breast cancer.